The title compound C21,H22,N3O2P2S3I, Mr=633. 44 crystallizes in themonoclinic, space group P21/a, with a= 8. 784 (3), b= 19. 900 (5), c = 16. 022 (4)A, β=98. 40(2)° V=2770. 6 A', Z=4, Dc= 1. 52 g/cm3, F(000...The title compound C21,H22,N3O2P2S3I, Mr=633. 44 crystallizes in themonoclinic, space group P21/a, with a= 8. 784 (3), b= 19. 900 (5), c = 16. 022 (4)A, β=98. 40(2)° V=2770. 6 A', Z=4, Dc= 1. 52 g/cm3, F(000)=1264, μ=125. 45 cm-l, R=0. 078, Rw=0. 067. In the molecule, each P atom is coordinated byO, N, S and C atoms with a distorted tetrahedral coordination configuration.展开更多
文摘The title compound C21,H22,N3O2P2S3I, Mr=633. 44 crystallizes in themonoclinic, space group P21/a, with a= 8. 784 (3), b= 19. 900 (5), c = 16. 022 (4)A, β=98. 40(2)° V=2770. 6 A', Z=4, Dc= 1. 52 g/cm3, F(000)=1264, μ=125. 45 cm-l, R=0. 078, Rw=0. 067. In the molecule, each P atom is coordinated byO, N, S and C atoms with a distorted tetrahedral coordination configuration.
